Mounjaro®
Starting from £179.99/mo
Start journey Learn morePepto-Bismol is one of the most common remedies people reach for when semaglutide causes nausea or an upset stomach — and it is a reasonable instinct. There is no known pharmacokinetic interaction between bismuth subsalicylate (the active ingredient in Pepto-Bismol) and semaglutide, but the picture is more nuanced than a simple yes or no. Because semaglutide slows how quickly your stomach empties, any medicine you take by mouth (including over-the-counter remedies) may be absorbed differently than usual. These are prescription-only medicines, so a prescriber or pharmacist who knows your full history is always the right person to ask before adding anything new to the mix.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating GLP-1 receptors, which sends signals that reduce appetite and slow the movement of food through the stomach. That slowing (called delayed gastric emptying) is part of what makes the medicine effective for weight management. It also explains why nausea, bloating, loose stools and indigestion are among the side effects people most commonly notice, particularly after starting treatment or moving to a higher dose.
The NHS semaglutide medicines page lists nausea, diarrhoea, constipation and stomach discomfort as common side effects, and notes that they are generally most noticeable in the first few weeks. For most people, the body adjusts. That adjustment period is exactly when reaching for something like Pepto-Bismol feels most tempting.
Knowing this context matters because the same gastric-slowing that causes those symptoms also affects the speed at which any other oral medicine or remedy you swallow reaches your small intestine for absorption. The effect on most over-the-counter products is modest and unlikely to be clinically significant, but it is not nothing — especially for someone who is also taking other medicines regularly.
If you want to understand more about how semaglutide works at a molecular level, our page on the semaglutide peptide itself goes into the mechanism in more depth.
Bismuth subsalicylate, the active compound in Pepto-Bismol, is not listed as a contraindicated or interacting substance in the semaglutide Summary of Product Characteristics. There is no documented pharmacokinetic clash. That said, the absence of a direct drug interaction does not make any remedy automatically appropriate for everyone on semaglutide.
The more relevant consideration for most people is the salicylate component. Aspirin is also a salicylate, and guidance around bismuth-subsalicylate products generally advises caution for people who take blood-thinning medicines, have a history of ulcers or gastrointestinal bleeding, or are sensitive to aspirin. If any of those apply to you, the conversation with your pharmacist becomes more important, not less.
A second practical point: Pepto-Bismol coats and settles the stomach lining, which can be genuinely soothing for nausea or loose stools. But because semaglutide keeps food in the stomach longer, things may not move on in the usual timeframe. Taking a remedy designed to slow gut transit on top of a medicine that already does that is worth flagging to whoever is overseeing your treatment.
You can read more about specific concerns around Wegovy and Pepto-Bismol on our dedicated page covering whether you can take Pepto-Bismol with Wegovy.
The first thing worth knowing is that most gut side effects from semaglutide are transient. They tend to peak in the days immediately after an injection and fade before the next one is due. Small meals, eating slowly, reducing fatty or spicy foods and staying well hydrated all make a measurable difference for most people, and they cost nothing and carry no interaction risk.
If symptoms are genuinely disruptive, the right first call is your prescriber, not the pharmacy shelf. A slower dose escalation, or staying at the current dose for longer before moving up, is a common and effective clinical response. Jumping to remedies without that conversation can sometimes mask symptoms that are worth reporting, or even slow down the dose adjustment that would actually help.
When a remedy is needed, plain antacids (such as those containing calcium carbonate or magnesium) are generally considered lower-risk than bismuth-containing products for people on prescription weight-loss medicines. Your pharmacist can walk you through the options in a couple of minutes. Many people find this conversation easiest to have when collecting a repeat, or, if you are managing treatment through an online service, via the aftercare team.
For a broader look at how semaglutide works for weight management and what the treatment journey typically involves, our main semaglutide overview covers the key ground. If you are considering the cost of private treatment, our Wegovy cost page sets out what is typically included in a legitimate private prescription price.
Most nausea from semaglutide is inconvenient rather than serious. There are, though, symptoms that warrant prompt medical attention rather than an over-the-counter remedy. Severe, persistent abdominal pain (particularly if it radiates towards the back) should be assessed by a doctor, because it can be a sign of acute pancreatitis, a known but infrequent side effect highlighted in a January 2026 MHRA Drug Safety Update for GLP-1 medicines. The same applies to signs of significant dehydration from repeated vomiting or diarrhoea.
The MHRA Yellow Card scheme lets patients report suspected side effects directly, which contributes to ongoing post-market safety monitoring for medicines like semaglutide. It takes a few minutes and is open to anyone.
If you are on Wegovy through a service like ours, the aftercare team is available seven days a week precisely for questions like these, so you do not need to sit with uncertainty until a weekday GP slot opens up. Think of it as the equivalent of being able to ask the pharmacist a question before you reach the checkout, rather than at 9pm on a Sunday with a half-read leaflet.
Our clinical team profiles, including the prescribers who oversee treatment at nume, are available on the clinical team page if you want to understand who is reviewing your care.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.